The lung is a key target of the cytokine storm that can be triggered by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the widespread clinical …

Background Pneumonia is a common and potentially serious illness. Corticosteroids have
been suggested for the treatment of different types of infection, however their role in the …

Background Since early December 2019, the 2019 novel coronavirus disease (COVID-19)
has caused pneumonia epidemic in Wuhan, Hubei province of China. This study aimed to …

The novel coronavirus disease 2019 (COVID-19) is an acute infectious disease caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently …

Pneumonia is a type of acute lower respiratory infection that is common and severe. The
outcome of lower respiratory infection is determined by the degrees to which immunity is …

Background Specific treatments for influenza are limited to neuraminidase inhibitors and
adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions …

Pneumonia and acute respiratory distress syndrome are common and important causes of
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …

Purpose Severe community-acquired pneumonia (SCAP) is still associated with substantial
morbidity and mortality. In this point-of-view review paper, a group of experts discuss the …

Background Our aim was to evaluate the benefits and harms of adjunctive corticosteroids in
adults hospitalized with community-acquired pneumonia (CAP) using individual patient data …

Community-acquired pneumonia is a leading cause of death. Risk factors include older age
and medical comorbidities. Diagnosis is suggested by a history of cough, dyspnea, pleuritic …